BARCLAYS PLC SNSE — SENSEI BIOTHERAPEUTICS INC

Ownership history in BARCLAYS PLC  ·  4 quarters on record

AI Ownership Summary

BARCLAYS PLC reported SENSEI BIOTHERAPEUTICS INC (SNSE) in 4 quarterly 13F filings from 2025 Q1 through 2026 Q3. The latest visible filing shows SNSE at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this SNSE ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was BARCLAYS PLC's position in SENSEI BIOTHERAPEUTICS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q3

SNSE was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.0% in 2026 Q3

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2025 Q1 to 2026 Q3

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

SNSE stock page BARCLAYS PLC fund profile BARCLAYS PLC full holdings
How BARCLAYS PLC held SNSE — position size vs. price
% of Fund (quarterly)
📋 Quarterly Holdings History 3 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q3 ADDED — — — 34,346 +21,934 +176.7% 0.00% $1.0M 2026-11-06 $19.20
2026 Q2 ADDED — — — 12,412 +9,854 +385.2% 0.00% $310K 2026-08-14 $32.34
2025 Q1 REDUCED — — — 2,558 -836 -24.6% 0.00% $1K 2025-05-15 $6.96
1 older quarter hidden  —  Sign in free or upgrade to Premium to see full history

🏢 Other funds also holding SNSE

As of 2026 Q3 — sorted by position size

Richmond Investment Services, LLC 0.72% Candriam S.C.A. 3Y 7Y 0.04% China Universal Asset Management Co., Ltd. 3Y 0.01% Freestone Capital Holdings, LLC 3Y 7Y 0.01% State of Wyoming 3Y 0.0% Squarepoint Ops LLC 3Y 7Y 0.0% FINANCIAL CONSULATE, INC 3Y 7Y 0.0% GEODE CAPITAL MANAGEMENT, LLC 3Y 7Y 0.0% Physician Wealth Advisors, Inc. 3Y 0.0% Fortitude Family Office, LLC 0.0%

FAQ About BARCLAYS PLC and SNSE

These are the practical questions this page is built to answer before you even open the full history table.

How long has BARCLAYS PLC reported owning SNSE?

BARCLAYS PLC reported SNSE across 3 quarterly 13F filings, from 2025 Q1 through 2026 Q3.

What was the largest reported SNSE position in BARCLAYS PLC's portfolio?

The largest reported portfolio weight for SNSE was 0.00% in 2026 Q3.

What is the latest reported SNSE position on this page?

The most recent filing on this page is 2026 Q3, when BARCLAYS PLC reported 34,346 shares, equal to 0.00% of portfolio, with an estimated market value of $1.0M.

What does the chart on this SNSE ownership page compare?

The chart compares BARCLAYS PLC's quarterly SNSE portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did BARCLAYS PLC time their SNSE position?

Based on 13F filing dates vs. subsequent SNSE price moves, BARCLAYS PLC correctly timed 0 out of 3 reported position changes (0%).

← Back to BARCLAYS PLC Holdings